Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 8—August 2015
Research

Hospital Resource Utilization and Patient Outcomes Associated with Respiratory Viral Testing in Hospitalized Patients

Sunita MulpuruComments to Author , Shawn D. Aaron, Paul E. Ronksley, Nadine Lawrence, and Alan J. Forster
Author affiliations: Ottawa Hospital Research Institute, Ottawa (S. Mulpuru, S.D. Aaron, N. Lawrence, A.J. Forster); University of Ottawa, Ottawa, Ontario, Canada (S. Mulpuru, S.D. Aaron, A.J. Forster); The Ottawa Hospital, Ottawa (S. Mulpuru, S.D. Aaron, A.J. Forster); University of Calgary, Calgary, Alberta, Canada (P.E. Ronksley)

Main Article

Table 3

Laboratory, prescription, radiology, and procedure use among hospitalized patients with positive and negative NP swab samples, Ottawa, Ontario, Canada, 2004–2012*

Variable No. (%) negative NP swab samples, n = 2,302 No. (%) positive NP swab samples, n = 420 No. (%) total swab samples, N = 2,722 p value
Antibiotic use 2,204 (95.7) 397 (94.5) 2,601 (95.6) 0.265
Antiviral use 305 (13.2) 166 (39.5) 471 (17.3) <0.001
Blood cultures 1,813 (78.8) 340 (81.0) 2153 (79.1) 0.309
Sputum cultures 979 (42.5) 167 (39.8) 1146 (42.1) 0.291
Bronchoscopy 147 (6.4) 20 (4.8) 167 (6.1) 0.202
CT scan of thorax 599 (26.0) 83 (19.8) 682 (25.1) 0.006
Chest radiograph 1,293 (56.2) 229 (54.5) 1,522 (55.9) 0.532

*NP, nasopharyngeal; CT, computed tomography.

Main Article

Page created: July 14, 2015
Page updated: July 14, 2015
Page reviewed: July 14, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external